• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

寻求治疗处方阿片类药物使用障碍的概率和预测因素:一项全国性研究。

Probability and predictors of treatment-seeking for prescription opioid use disorders: a national study.

机构信息

Department of Psychiatry, New York State Psychiatric Institute/College of Physicians and Surgeons, Columbia University, New York, NY 10032, United States.

出版信息

Drug Alcohol Depend. 2013 Jul 1;131(1-2):143-8. doi: 10.1016/j.drugalcdep.2012.12.013. Epub 2013 Jan 8.

DOI:10.1016/j.drugalcdep.2012.12.013
PMID:23306097
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3636152/
Abstract

BACKGROUND

Prescription opioid use disorders are the second most common drug use disorder behind only cannabis use disorders. Despite this, very little is known about the help-seeking behavior among individuals with these disorders.

METHODS

The sample included respondents of the Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) with a lifetime diagnosis of prescription drug use disorders (N=623). Unadjusted and adjusted hazard ratios are presented for time to first treatment-seeking by sociodemographic characteristics and comorbid psychiatric disorders.

RESULTS

The lifetime cumulative probability of treatment seeking was 42% and the median delay from prescription drug use disorder onset to first treatment was 3.83 years. Having an earlier onset of prescription opioid use disorder and a history of bipolar disorder, major depression disorder, specific phobia and cluster B personality disorders predicted shorter delays to treatment.

CONCLUSIONS

Although some comorbid psychiatric disorders increase the rate of treatment-seeking and decrease delays to first-treatment contact rates of treatment-seeking for prescription drug use disorder are low, even when compared with rates of treatment for other substance use disorders. Given the high prevalence and adverse consequences of prescription drug use disorder, there is a need to improve detection and treatment of prescription opioid use disorder.

摘要

背景

处方阿片类药物使用障碍是仅次于大麻使用障碍的第二常见药物使用障碍。尽管如此,对于这些障碍患者的寻求帮助行为,人们知之甚少。

方法

该样本包括具有终生处方药物使用障碍诊断的国家酒精和相关条件流行病学调查(NESARC)第 2 波的受访者(N=623)。根据社会人口统计学特征和共病精神障碍,呈现了首次治疗寻求的无调整和调整后的风险比。

结果

终生治疗寻求的累积概率为 42%,从处方药物使用障碍发病到首次治疗的中位数延迟为 3.83 年。处方阿片类药物使用障碍的发病年龄较早,以及有双相情感障碍、重度抑郁症、特定恐惧症和 B 群人格障碍病史,预测治疗延迟时间更短。

结论

尽管一些共病精神障碍会增加治疗寻求的比率,并减少首次治疗接触的延迟,但与其他物质使用障碍的治疗率相比,处方药物使用障碍的治疗寻求率仍然较低。鉴于处方药物使用障碍的高患病率和不良后果,需要提高对处方阿片类药物使用障碍的检测和治疗。

相似文献

1
Probability and predictors of treatment-seeking for prescription opioid use disorders: a national study.寻求治疗处方阿片类药物使用障碍的概率和预测因素:一项全国性研究。
Drug Alcohol Depend. 2013 Jul 1;131(1-2):143-8. doi: 10.1016/j.drugalcdep.2012.12.013. Epub 2013 Jan 8.
2
Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions.心境和焦虑障碍及其与非医疗处方类阿片类药物使用和处方类阿片类药物使用障碍的关联:来自国家酒精相关条件流行病学研究的纵向证据。
Psychol Med. 2012 Jun;42(6):1261-72. doi: 10.1017/S0033291711002145. Epub 2011 Oct 17.
3
Probability and predictors of treatment-seeking for substance use disorders in the U.S.美国物质使用障碍寻求治疗的概率及预测因素
Drug Alcohol Depend. 2015 Apr 1;149:136-44. doi: 10.1016/j.drugalcdep.2015.01.031. Epub 2015 Feb 9.
4
Probability and predictors of first treatment contact for anxiety disorders in the United States: analysis of data from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).美国焦虑障碍首次治疗接触的概率和预测因素:来自国家酒精相关情况流行病学调查(NESARC)的数据分析。
J Clin Psychiatry. 2013 Nov;74(11):1093-100. doi: 10.4088/JCP.13m08361.
5
Treatment utilization among persons with opioid use disorder in the United States.美国阿片类药物使用障碍患者的治疗利用情况。
Drug Alcohol Depend. 2016 Dec 1;169:117-127. doi: 10.1016/j.drugalcdep.2016.10.015. Epub 2016 Oct 19.
6
Duration of opioid prescriptions predicts incident nonmedical use of prescription opioids among U.S. veterans receiving medical care.阿片类药物处方持续时间可预测接受医疗服务的美国退伍军人中处方类阿片药物的非医疗使用的发生情况。
Drug Alcohol Depend. 2018 Oct 1;191:348-354. doi: 10.1016/j.drugalcdep.2018.07.008. Epub 2018 Aug 22.
7
Gender and nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions - III.性别与非医疗处方阿片类药物使用及《精神疾病诊断与统计手册》第5版非医疗处方阿片类药物使用障碍:酒精及相关状况全国流行病学调查-III的结果
Drug Alcohol Depend. 2015 Nov 1;156:47-56. doi: 10.1016/j.drugalcdep.2015.08.026. Epub 2015 Sep 2.
8
Use of Drug Treatment Services Among Adults With Opioid Use Disorder: Rates, Patterns, and Correlates.药物治疗服务在阿片类药物使用障碍成年患者中的使用情况:使用率、模式和相关因素。
Psychiatr Serv. 2019 Nov 1;70(11):992-999. doi: 10.1176/appi.ps.201900163. Epub 2019 Jul 30.
9
Prospective follow-up of empirically derived Alcohol Dependence subtypes in wave 2 of the National Epidemiologic Survey on Alcohol And Related Conditions (NESARC): recovery status, alcohol use disorders and diagnostic criteria, alcohol consumption behavior, health status, and treatment seeking.前瞻性随访基于全国酒精相关情况和条件的流行病学调查(NESARC)第 2 波的经验衍生的酒精依赖亚型:康复状况、酒精使用障碍和诊断标准、饮酒行为、健康状况和寻求治疗。
Alcohol Clin Exp Res. 2010 Jun;34(6):1073-83. doi: 10.1111/j.1530-0277.2010.01183.x. Epub 2010 Apr 9.
10
Comparisons of Cocaine-Only, Opioid-Only, and Users of Both Substances in the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).《酒精及相关疾病国家流行病学调查》(NESARC)中仅使用可卡因者、仅使用阿片类药物者以及同时使用这两种物质者的比较。
Subst Use Misuse. 2016;51(5):553-64. doi: 10.3109/10826084.2015.1122063. Epub 2016 Mar 22.

引用本文的文献

1
Narrative review: Managing buprenorphine and opioid use disorder in the perioperative setting.叙述性综述:围手术期丁丙诺啡与阿片类物质使用障碍的管理
Pain Pract. 2025 Jan;25(1):e13427. doi: 10.1111/papr.13427. Epub 2024 Oct 25.
2
Empirically contrasting urine drug screening-based opioid use disorder treatment outcome definitions.基于尿液药物筛查的阿片类药物使用障碍治疗结果定义的实证对比。
Addiction. 2024 Jul;119(7):1289-1300. doi: 10.1111/add.16494. Epub 2024 Apr 14.
3
Impact of Depressive Symptom Severity on Buprenorphine/Naloxone and Methadone Outcomes in People With Prescription-Type Opioid Use Disorder: Results From a Pragmatic Randomized Controlled Trial.抑郁症状严重程度对有处方类阿片使用障碍者丁丙诺啡/纳洛酮和美沙酮治疗结局的影响:一项实用随机对照试验的结果。
J Dual Diagn. 2024 Jul-Sep;20(3):189-200. doi: 10.1080/15504263.2024.2329267. Epub 2024 Apr 5.
4
The economic impact of cannabis use disorder and dementia diagnosis in veterans diagnosed with traumatic brain injury.患有创伤性脑损伤的退伍军人中,大麻使用障碍和痴呆症诊断的经济影响。
Front Neurol. 2024 Jan 12;14:1261144. doi: 10.3389/fneur.2023.1261144. eCollection 2023.
5
Examining buprenorphine diversion through a harm reduction lens: an agent-based modeling study.从减少伤害的角度审视丁丙诺啡的滥用:基于代理的建模研究。
Harm Reduct J. 2023 Oct 17;20(1):150. doi: 10.1186/s12954-023-00888-6.
6
What Brings You in Today? Sex, Race, Substance Type, and Other Sociodemographic and Health-Related Characteristics Predict if Substance Use is the Main Reason for a Clinical Encounter.今天是什么原因让你来看病?性别、种族、物质类型以及其他社会人口学和健康相关特征可预测物质使用是否是临床就诊的主要原因。
Yale J Biol Med. 2023 Sep 29;96(3):277-291. doi: 10.59249/UDRG5942. eCollection 2023 Sep.
7
Massachusetts Prevalence of Opioid Use Disorder Estimation Revisited: Comparing a Bayesian Approach to Standard Capture-Recapture Methods.马萨诸塞州阿片类药物使用障碍患病率评估的再探讨:贝叶斯方法与标准捕获-再捕获方法的比较。
Epidemiology. 2023 Nov 1;34(6):841-849. doi: 10.1097/EDE.0000000000001653. Epub 2023 Sep 26.
8
Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention.物质使用障碍:分类、流行病学、神经生物学、临床方面、治疗与预防的全面更新
World Psychiatry. 2023 Jun;22(2):203-229. doi: 10.1002/wps.21073.
9
Novel digital approaches to the assessment of problematic opioid use.评估阿片类药物使用问题的新型数字方法。
BioData Min. 2022 Jul 15;15(1):14. doi: 10.1186/s13040-022-00301-1.
10
Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis.加拿大安大略省 COVID-19 大流行对提供阿片类激动剂治疗带药回家方案的影响:基于人群的时间序列分析。
Int J Drug Policy. 2022 May;103:103644. doi: 10.1016/j.drugpo.2022.103644. Epub 2022 Mar 1.

本文引用的文献

1
Age of onset of life-time mental disorders and treatment contact.一生中精神障碍发病年龄和治疗接触情况。
Soc Psychiatry Psychiatr Epidemiol. 2013 May;48(5):835-43. doi: 10.1007/s00127-012-0601-y. Epub 2012 Oct 18.
2
Probability and predictors of remission from life-time prescription drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.从终身处方药使用障碍中缓解的可能性和预测因素:来自国家酒精和相关条件的流行病学调查。
J Psychiatr Res. 2013 Jan;47(1):42-9. doi: 10.1016/j.jpsychires.2012.08.019. Epub 2012 Sep 15.
3
American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.美国介入性疼痛医师学会(ASIPP)慢性非癌痛患者阿片类药物负责任处方指南:第 2 部分——指南。
Pain Physician. 2012 Jul;15(3 Suppl):S67-116.
4
Scientists, officials eye tools aimed at combating abuse of painkillers.科学家和官员关注旨在打击止痛药滥用的工具。
JAMA. 2012 Jan 4;307(1):19-21. doi: 10.1001/jama.2011.1900.
5
Influence of comorbid mental disorders on time to seeking treatment for major depressive disorder.共病精神障碍对重度抑郁症寻求治疗时间的影响。
Med Care. 2012 Mar;50(3):227-32. doi: 10.1097/MLR.0b013e318241eb5e.
6
Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions.心境和焦虑障碍及其与非医疗处方类阿片类药物使用和处方类阿片类药物使用障碍的关联:来自国家酒精相关条件流行病学研究的纵向证据。
Psychol Med. 2012 Jun;42(6):1261-72. doi: 10.1017/S0033291711002145. Epub 2011 Oct 17.
7
The relationship between personality disorders and mental health, substance use severity and quality of life among injecting drug users.人格障碍与注射吸毒者的心理健康、物质使用严重程度和生活质量之间的关系。
Med J Aust. 2011 Aug 1;195(3):S16-21. doi: 10.5694/j.1326-5377.2011.tb03260.x.
8
Association between opioid prescribing patterns and opioid overdose-related deaths.阿片类药物处方模式与阿片类药物过量相关死亡之间的关联。
JAMA. 2011 Apr 6;305(13):1315-21. doi: 10.1001/jama.2011.370.
9
Societal costs of prescription opioid abuse, dependence, and misuse in the United States.美国处方阿片类药物滥用、依赖和误用的社会成本。
Pain Med. 2011 Apr;12(4):657-67. doi: 10.1111/j.1526-4637.2011.01075.x. Epub 2011 Mar 10.
10
Development of lifetime comorbidity in the World Health Organization world mental health surveys.世界卫生组织世界精神卫生调查中终生共病的发展情况。
Arch Gen Psychiatry. 2011 Jan;68(1):90-100. doi: 10.1001/archgenpsychiatry.2010.180.